We are live on ! Find out more
SILK

Silk Road Medical, Inc. Common Stock

Delisted

SILK was delisted on the 16th of September, 2024.

101 hedge funds and large institutions have $859M invested in Silk Road Medical, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 55 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

677% more call options, than puts

Call options by funds: $101K | Put options by funds: $13K

267% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 15

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

2% more funds holding

Funds holding: 99101 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

18% less capital invested

Capital invested by funds: $1.05B → $859M (-$187M)

Holders
101
Holders Change
+2
Holders Change %
+2.02%
% of All Funds
2.21%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
21
Increased
55
Reduced
15
Closed
18
Calls
$101K
Puts
$13K
Net Calls
+$88K
Net Calls Change
+$88K
Name Holding Trade Value Shares
Change
Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$593K +$299K +7,510 +70%
TAM
52
Tiverton Asset Management
Delaware
$554K +$566K +14,208 +507%
Ameriprise
53
Ameriprise
Minnesota
$497K +$3.59K +90 +0.6%
SIM
54
Spark Investment Management
New York
$481K
Squarepoint
55
Squarepoint
New York
$480K +$266K +6,686 +83%
MA
56
MYDA Advisors
New York
$455K -$1.8M -45,100 -76%
SBH
57
Segall Bryant & Hamill
Illinois
$409K +$502K +12,604 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$376K +$193K +4,843 +72%
QT
59
Quantbot Technologies
New York
$349K +$428K +10,755 New
ZP
60
Zimmer Partners
New York
$325K
NAM
61
Nexpoint Asset Management
Texas
$325K +$398K +10,000 New
WMSA
62
Weiss Multi-Strategy Advisers
New York
$325K +$398K +10,000 New
PPA
63
Parametric Portfolio Associates
Washington
$294K +$61.7K +1,548 +21%
UBS Group
64
UBS Group
Switzerland
$292K -$44.5K -1,117 -76%
FAM
65
Fred Alger Management
New York
$260K -$538K -13,500 -63%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$247K +$114K +2,874 +61%
RG
67
Rathbones Group
United Kingdom
$244K +$298K +7,490 New
AIG
68
American International Group
New York
$240K +$118K +2,959 +67%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$212K +$97.9K +2,458 +58%
JP Morgan Chase
70
JP Morgan Chase
New York
$203K +$120K +3,023 +94%
RIA
71
Realta Investment Advisors
Delaware
$201K +$245K +6,150 New
Morgan Stanley
72
Morgan Stanley
New York
$191K -$227K -5,703 -49%
Barclays
73
Barclays
United Kingdom
$191K +$55K +1,380 +31%
MIM
74
MetLife Investment Management
New Jersey
$186K +$56.7K +1,422 +33%
MCIM
75
Meadow Creek Investment Management
Georgia
$153K +$157K +3,944 +527%

SILK Hedge Fund Activity: Q3 2019 in Review

101 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2019, worth a combined $859M — down 18% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SILK positions and 18 closed out — a net gain of 3 holders — while 55 added to existing stakes and 15 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $98M. The largest seller was Warburg Pincus, cutting an estimated $191M.

  • 101 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2019, up from 99 in Q2 2019.
  • Funds reported $859M of Silk Road Medical, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
  • 21 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2019 and 18 closed out, a net change of +3 holders.
  • The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2019 was Janus Henderson Group, an estimated $98M added.
  • The largest Silk Road Medical, Inc. Common Stock seller in Q3 2019 was Warburg Pincus, an estimated $191M sold.

Based on aggregated 13F filings for Q3 2019.